MADELINE LEWIS: Open Payments
NPI 1851054787 · BEREA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 71 payments from 19 companies in 2025. Trend: 2023 $1,388 · 2024 $1,222 · 2025 $1,361
Food & beverage: $1,361
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 6 | $265 |
| ABBVIE INC. | 22 | $221 |
| Alkermes, Inc. | 5 | $163 |
| Vanda Pharmaceuticals Inc. | 10 | $156 |
| Neurocrine BioSciences, Inc. | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Almatica Pharma LLC | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $33 |
Products named: Azstarys, VRAYLAR, FANAPT, LYBALVI, INGREZZA, LOREEV XR, REXULTI, CAPLYTA.
Industry payments across KY — which companies pay providers there.
